Seth Klarman’s portfolio: Baupost Group 13F holdings

Quarterly SEC 13F-HR filingsCIK 0001061768Latest: Q2 2026

Q3 2017 filing in brief

In its Q3 2017 13F, filed November 13, 2017, Baupost Group reported $8.0B across 37 US positions. The largest: LNG (11.6%), SYF (11.3%), VSAT (10.6%), QRVO (7.9%), ALLERGAN PLC (7.6%). In the quarter it opened 5 positions, sold out of 9, added to 5 and trimmed 4; positions opened and sold out came to 7.6% of the portfolio's value.

Methodology

Holdings come from the manager’s Form 13F-HR filings on SEC EDGAR, with amendments applied. Values and shares are reported at quarter-end; the filing date is when the report became public. These disclosures show reported long positions and listed options, not the manager’s entire portfolio or its trades since quarter-end.

Quarterly changes compare shares with the immediately preceding quarter on file. New and exited positions appear or disappear; added and trimmed positions change their share count by more than 1%. A share change can also reflect a stock split or other corporate action.

Opened and sold out is the value of new positions plus the prior value of exited positions, divided by the average of the two quarters’ reported portfolio values. It excludes changes to positions still held. Reported value growth includes price changes and is not a measure of investment performance. Largest-five and largest-ten weights exclude options.

Holdings

Filed Nov 13, 2017

  • 5 New
  • 5 Added
  • 4 Trimmed
  • 9 Exited

37 positions at September 30, 2017. Q/Q change compares shares with the preceding quarter.

RowTickerIssuerStatus
1LNGCHENIERE ENERGY INC$934M20.7M11.64%0.0%Held
2SYFSYNCHRONY FINL$910M29.3M11.34%0.0%Held
3VSATVIASAT INC$846M13.2M10.55%0.0%Held
4QRVOQORVO INC$636M9.0M7.93%0.0%Held
5—ALLERGAN PLC$608M3.0M7.57%+21.9%Added
6—COLONY NORTHSTAR INC$602M47.9M7.50%0.0%Held
7—TWENTY FIRST CENTY FOX INC$505M19.1M6.29%0.0%Held
8ARANTERO RES CORP$476M23.9M5.93%+12.9%Added
9PBFPBF ENERGY INC$434M15.7M5.41%0.0%Held
10—THERAVANCE BIOPHARMA INC$319M9.3M3.97%+0.4%Held
11—DELL TECHNOLOGIES INC$236M3.1M2.94%−46.0%Trimmed
12—TWENTY FIRST CENTY FOX INC$190M7.4M2.37%+1.5%Added
13—KERYX BIOPHARMACEUTICALS INC$183M25.8M2.28%0.0%Held
14CAHCARDINAL HEALTH INC$169M2.5M2.11%+24.6%Added
15—EXPRESS SCRIPTS HLDG CO$162M2.6M2.02%0.0%Held
16VRTVEURVERITIV CORP$99M3.1M1.24%+0.3%Held
17ATRAGBXATARA BIOTHERAPEUTICS INC$89M5.4M1.11%0.0%Held
18MCKMCKESSON CORP$77M500.0K0.96%—New
19PRTKEURPARATEK PHARMACEUTICALS INC$60M2.4M0.75%0.0%Held
20—CHIPMOS TECHNOLOGIES INC$59M3.0M0.73%−13.2%Trimmed
21—AMC ENTMT HLDGS INC$52M3.6M0.65%—New
22—GTY TECHNOLOGY HOLDINGS INC$46M4.4M0.57%0.0%Held
23CDEVEURCENTENNIAL RESOURCE DEV INC$42M2.4M0.52%0.0%Held
24CARAVIS BUDGET GROUP$39M1.0M0.49%−74.1%Trimmed
25—FORWARD PHARMA A/S$39M6.5M0.49%+1.6%Added
26NGNOVAGOLD RES INC$39M9.5M0.49%0.0%Held
27TBPH 3.25 11/01/23THERAVANCE BIOPHARMA INC$37M30.0M0.46%0.0%Held
28—CASCADIAN THERAPEUTICS INC$36M8.7M0.44%0.0%Held
29—SABAN CAP ACQUISITION CORP$23M2.3M0.29%0.0%Held
30—SILVER RUN ACQUISITION$22M2.1M0.27%−67.5%Trimmed
31RUNSUNRUN INC$16M2.8M0.20%0.0%Held
32ABGAMERISOURCEBERGEN CORP$16M188.8K0.19%—New
33TMQTRILOGY METALS INC NEW$10M10.6M0.12%0.0%Held
34—OREXIGEN THERAPEUTICS INC$5M2.2M0.06%0.0%Held
35PXDEURPIONEER NAT RES CO$4M28.9K0.05%—New
36—SIMPLY GOOD FOODS CO$2M1.0M0.03%—New
37—SABAN CAP ACQUISITION CORP$1M1.2M0.02%0.0%Held
9 exited positions

Positions held in the preceding quarter and absent from this filing. Values and shares are from the preceding quarter.

TickerIssuerPrevious valuePrevious shares
QCOMQUALCOMM INC$288M5.2M
—SPIRIT RLTY CAP INC NEW$67M9.0M
—CONYERS PK ACQUISITION$44M3.7M
BATRKLIBERTY MEDIA CORP DELAWARE$31M1.3M
CACCCREDIT ACCEP CORP MICH$25M98.7K
INVA 2.125 01/15/23THERAVANCE INC$15M17.0M
—AMERICAN INTL GROUP INC$7M354.8K
—SILVER RUN ACQUISITION$4M2.2M
—CONYERS PK ACQUISITION$3M1.2M
Every quarter on file (53)

From the manager’s Form 13F-HR filings on SEC EDGAR, amendments applied. Long US positions only; not a recommendation.